Learn what compliant suppliers need to know to navigate the moratorium, avoid revocation pitfalls, and continue serving Medicare beneficiaries in an era of elevated scrutiny.

Join this discussion about the recent passage of a bill that could expand the number of drugs covered under the DMEPOS infusion benefit. Learn what drugs might qualify under this benefit and review the next steps toward its implementation.

This webinar will examine the home infusion and durable medical equipment (DME) legislative provisions recently highlighted during the House Energy and Commerce Committee hearing. Speakers will review the current policy landscape and outline key considerations as stakeholders look ahead to 2026.

Join NHIA as we cover critical updates to ensure ongoing participation in Part D Prescription Drugs Plans, including how to prepare to enroll with the Medicare Transactions Facilitator (MTF) Data Module (starting June 2025).

Join Connie Sullivan, NHIA President & CEO, Shea McCarthy, Director of Legislative Affairs, and Bill Noyes, NHIA Sr VP of Reimbursement Policy for a review of the 2024 end of year government funding on health care policies and what lies ahead for the next Congress.

Catch up with NHIA on the latest regulatory and legislative updates affecting home and alternate site infusion providers.

Catch up with the latest billing policy updates as well as regulatory and legislative action affecting home and alternate site infusion providers.

This initial Talk Infusion Webinar of 2024 will provide members with an outlook for legislative priorities for NHIA including the Preserving Patient Access to Home Infusion Act, as well as the status of other efforts to reform Part B DMEPOS.

Catch the latest regulatory updates impacting the home and alternate site infusion industry as we gear up for 2024.